Beres Industrial, a subsidiary of Beres Rt, a vitamins and mineral supplement producer in the Netherlands, is to purchase Hungarian firm Pharmasol, which produces pharmaceuticals, reports the MTI Econews service. Beres is said to have been attracted to Pharmasol by its 5% share of the Hungarian pharmaceuticals market and the fact that it is licensed to produce medicines. Beres currently leases production facilities for its tablets.
The purchase by Beres was approved by 97% of the Pharmasol shareholders, and Beres is thought to have paid around 370 million forint ($2.6 million).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze